All News

    What I Learned From My Cancer Nurse Maria

    May 25th 2025, 2:00pm

    Article

    Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery and recovery.

    Helping the Team While Helping Others

    May 24th 2025, 6:00pm

    Article

    Kathleen Shuey, M.S., RN, SCON, ACNS-BC, listens and guides us in the right direction in caring for our oncology population.

    Teaching, Writing, Healing: The Intersections of My Cancer Journey

    May 24th 2025, 2:00pm

    Article

    Fifteen years after being diagnosed with small lymphocytic lymphoma, I’ve found healing and meaning in the work I love and the life I’m grateful to live.

    True Grit: The Spirit of an Extraordinary Healer

    May 23rd 2025, 9:00pm

    Article

    Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.

    Uniting Pediatric and Adult Oncologists to Advance AYA Lymphoma Care

    May 23rd 2025, 8:00pm

    Video

    Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives.

    Making Something Positive out of Breast Cancer

    May 23rd 2025, 7:00pm

    Article

    After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery shirts and pillows.

    Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

    May 23rd 2025, 5:00pm

    Article

    I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

    GLP-1 Drugs Linked to Fewer Obesity-Related Cancers

    May 23rd 2025, 3:00pm

    Article

    GLP-1 drugs lowered rates of obesity-related cancers and death versus DPP-4s, with no increased cancer risk, study finds.

    Breaking Down Treatment Variables in AYA Patients With Cancer

    May 23rd 2025, 1:00pm

    Article

    Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on lymphoma care.

    Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

    May 22nd 2025, 9:00pm

    Article

    Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.